San Jose, CA, 17th December 2018: OptraSCAN®, the leading On-Demand Digital Pathology solution provider has collaborated with Deenanath Mangeshkar Hospital & Research Center, affiliated to Lata Mangeshkar Medical Foundation, India to implement OptraSCAN’s affordable digital pathology solution along with Artificial Intelligence (AI) & Machine Learning (ML)-based image analysis solution for nuclear and membrane biomarker quantification.

“There is no denying that digital pathology adoption leads to better outcomes and brings the pathology community closer; and with advancements such as AI & ML-based algorithms, digital pathology has gone beyond”, said Dr. Sujit Joshi, Consulting Onco-Pathologist, Deenanath Mangeshkar Hospital. “We are excited to be using OptraSCAN’s whole slide scanning system with AI & ML-based solution as they promise to provide accurate and rapid assessment of nuclear and membrane biomarker analysis which is a great news for research and timely treatment in the oncology field.”

“As digital pathology is transforming modern healthcare, slowly but steadily many hospitals and labs are taking cognizance of its many benefits. Keeping true to its mission, OptraSCAN has been working to make digital pathology affordable, accessible and easy-to-implement for the pathologists’ community worldwide”, said Abhi Gholap, Founder & CEO, OptraSCAN®. “Such implementations will help expand the adoption of digital pathology to improve cancer research and allow more institutions to collaborate and see the true rewards of AI in pathology.”

“I am glad that with OptraSCAN, we are able to achieve our goal of adopting an end-to-end integrated digital pathology solution in our work system to derive the many distinct benefits it offers. This digital transformation will drive us to improve operational efficiency and to provide better outcomes”, said Dr. Mahesh Mandolkar, HOD – Pathology, Deenanath Mangeshkar Hospital.

OptraSCAN® On-Demand desktop scanning systems are cloud-enabled and provide the ultimate flexibility for storing, archiving and managing digital images and metadata. Convenient for Brightfield, Fluorescence, and Confocal whole slide imaging modalities; these small footprint, low and high throughput scanners are lightweight that can easily fit into small workspaces. OptraSCAN’s end-to-end solutions include TELEPath – a comprehensive telepathology solution, AI & ML-based image analysis solutions providing accurate, rapid and reproducible analysis of immuno-oncology, prostate cancer and immunohistochemistry applications.

 

About OptraSCAN:

OptraSCAN® are pioneers in the On-Demand Digital Pathology® System, focused on delivering fully integrated and affordable products, software and solutions via On-Demand or outright purchase model. An ISO 13485 certified company and CE marked whole slide scanners for IVD use, OptraSCAN is working to eliminate the barriers to “Go Digital” no matter the size of the pathology lab, the lab’s throughput or global location.

Nikon and OptraSCAN have entered into a strategic partnership to accelerate the adoption of affordable digital pathology in North America. Follow Us on LinkedIn and Twitter.

 

About Deenanath Mangeshkar Hospital:

Deenanath Mangeshkar Hospital & Research Center is a charitable, multi-specialty hospital located in the western part of India. Founded in 2001, Deenanath Mangeshkar Hospital is one of the premier hospital in India offering state-of-the-art diagnostic, therapeutic and intensive care facilities as a one-stop medical center.

 

Contacts:

Media Inquiries:

Shruti Soman | Manager – Marketing Communications | 91.20.66540900 | s.soman@optraventures.com

Sales Inquiries:

Mike Oria | Director of Sales – North America | 415.407.9658 | mike@optraventures.com

Anand Maiskar | VP – Sales & Business Development, RoW | 91.20.66540900 | A.Maiskar@optraventures.com

OR

platinum partners

gold partners

Silver Partners

Media Partners